The multicenter REFINE-ALS prospective trial for Radicava® (Edaravone), sponsored by Mitsubishi Tanabe Pharma America (MTPA), has been conducted in collaboration with Massachusetts General Hospital and Harvard Medical School Dr. James Berry, Director of Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI), shared the interim analysis from the REFINE-ALS… Read More..

FRISCO, TX, Dec. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Verde Bio Holdings, Inc. (OTCQB: VBHI), a growing oil and gas company, today issued its second quarter shareholder update, along with its 10-Q filing with the highlights of the Quarter and what is in store for the future. The… Read More..

ANN ARBOR, MI / ACCESSWIRE / December 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the Wall Street Analyzer, and Larry Heaton, Zomedica's Chief Executive Officer. Juan Costello, Senior Analyst… Read More..